Mace L. Rothenberg

Oncology

3601 21st Ave S
Nashville, TN 37232

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 15, 2023

Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop.

Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop.

Journal: Journal for immunotherapy of cancer

Published: April 28, 2023

Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data.

Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data.

Journal: Journal for immunotherapy of cancer

Published: May 30, 2021

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.

Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials.

Journal: JNCI cancer spectrum

Published: May 28, 2021

Price, Cost, and Value of Cancer Medicines: A Pharmaceutical Industry Perspective.

Price, Cost, and Value of Cancer Medicines: A Pharmaceutical Industry Perspective.

Journal: Cancer journal (Sudbury, Mass.)

Published: August 01, 2020

Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies.

Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies.

Journal: Annals of internal medicine

Published: July 07, 2020

Accelerating anticancer drug development - opportunities and trade-offs.

Accelerating anticancer drug development - opportunities and trade-offs.

Journal: Nature reviews. Clinical oncology

Published: October 03, 2018

Evaluating Treatment Effect Based on Duration of Response for a Comparative Oncology Study.

Evaluating Treatment Effect Based on Duration of Response for a Comparative Oncology Study.

Journal: JAMA oncology

Published: May 01, 2018

Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.

Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.

Journal: The oncologist

Published: March 13, 2018

Advantages of a Truly Open-Access Data-Sharing Model.

Advantages of a Truly Open-Access Data-Sharing Model.

Journal: The New England journal of medicine

Published: March 23, 2017

Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.

Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis.

Journal: The Lancet. Oncology

Published: July 21, 2016

Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.

Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 01, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026